Pfizer stock trades at $27.75, down 0.89%, below its $27.91 pivot
Pfizer stock trades at $27.75, down 0.89%, below its $27.91 pivot The Cryptonomist
Covered in this story
Analyst targets on Pfizer
- Scotiabank: $27.5 → $33 by Oct 2027 · Sector Outperform via GuruFocus
- BMO Capital Markets: $27.3 → $30 by Aug 2027 · Buy via 富途牛牛
- HSBC: $23.7 → $28 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PFE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Pfizer →Dalsna Finance is currently tracking 48 stories mentioning Pfizer, the earliest published 18 Jun 2026.
Summary aggregated from The Cryptonomist's public RSS feed. The full reporting belongs to The Cryptonomist — please read it on their site.